Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171895 · ClinicalTrials.gov registry record
Communication Training for Caregivers In Advanced Care Planning
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 49
- Enrollment target
NCT04171895: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04171895 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04171895 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop and test a new communication training to help caregivers communicate more effectively with their loved ones and healthcare professionals about advanced care planning.
Primary Outcome
Feasibility criteria will be met if the target number of participants (n=10) complete a training session within the planned timeframe.
Interventions
- OTHER Questionnaires
- OTHER Enhanced usual care
- OTHER Communication training Part 1 (no longer recruiting)
- OTHER Communication training Part II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2024-08-22 |
What the finished NCT04171895 record still lists
NCT04171895 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT04171895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04171895 about?
NCT04171895 is a clinical study titled "Communication Training for Caregivers In Advanced Care Planning". The purpose of this research study is to develop and test a new communication training to help caregivers communicate more effectively with their loved ones and healthcare professionals about advanced care planning.
What is the current status of trial NCT04171895?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2019-11-19. Estimated completion is 2024-08-22.
What interventions are being tested in trial NCT04171895?
The interventions under investigation include: Questionnaires (OTHER), Enhanced usual care (OTHER), Communication training Part 1 (no longer recruiting) (OTHER), Communication training Part II (OTHER).
Who is sponsoring clinical trial NCT04171895?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI